Eli Lilly: heart failure drug shows reduced risk of death

(CercleFinance.com) - Eli Lilly said on Monday that its drug Jardiance helps to reduce the risk of cardiovascular death and hospitalization by 25% in patients with and without diabetes who suffer from heart failure issues.


The Phase III trial also showed that Jardiance reduced the risk of first and recurrent hospitalization for heart failure by 30%, while significantly slowing the decline in kidney function.

Heart failure - which occurs when the heart cannot pump sufficient blood to the rest of the body - affects over 60 million people worldwide, with more than one million people being hospitalized due to the condition every year in the US.

Copyright (c) 2020 CercleFinance.com. All rights reserved.